-
LAMP1, CXCL10–CXCR3, and Macrophage Polarization
2026-09-18
The 2024 International Immunopharmacology study identifies LAMP1 as a state-dependent regulator of CXCL10–CXCR3 signaling and macrophage polarization. Its combination of pharmacologic CXCR3 antagonism, LAMP1 knockdown, autophagy readouts, and a poly(I:C)-induced lung injury model provides a mechanistic framework for interpreting inflammatory macrophage responses.
-
C34 TLR4 Inhibitor: Applied Research Workflows
2026-09-18
C34 is a selective small molecule TLR4 inhibitor for separating TLR4-driven inflammation from TLR2 and TLR9 responses. This workflow-focused guide shows how to apply it in macrophage, enterocyte, microglial, tissue, and exploratory in vivo models while improving controls and troubleshooting.
-
Ibotenic Acid: From Receptor Signal to Circuit Readout
2026-09-17
Ibotenic acid is an NMDA receptor agonist for dissecting how excitatory signaling becomes a measurable circuit phenotype. This guide connects compound selection, spatial controls, and time-resolved readouts with insights from a landmark mechanical-allodynia study.
-
Sulfaphenazole-Derived Sulfonamides Against M. tuberculosis
2026-09-17
Chen and colleagues optimized the Sulfaphenazole scaffold to retain antimycobacterial activity while reducing unwanted CYP2C9 inhibition. The lead analogue 10d combined measurable activity against Mycobacterium tuberculosis with weak CYP2C9 inhibition, illustrating a practical strategy for separating antibacterial efficacy from drug–drug interaction liability.
-
8-DY547-cGMP for CA2 PNN Research
2026-09-16
Use 8-DY547-cGMP to build fluorescence-based cGMP assay workflows alongside CA2 perineuronal-net measurements in Alzheimer’s disease models. The approach separates biochemical probe validation from tissue-level interpretation, helping researchers investigate signaling changes without mistaking fluorescent analog behavior for endogenous cGMP activity.
-
Tobramycin: From Ribosome to Translation
2026-09-15
A translational perspective on Tobramycin that connects 30S ribosome engagement, historical susceptibility evidence, resistance research, assay design, and practical reagent strategy for modern microbiology teams.
-
Anlotinib Hydrochloride: Angiogenesis Assay Guide
2026-09-15
Build quantitative angiogenesis and cancer research workflows around a multi-target tyrosine kinase inhibitor that links receptor phosphorylation to endothelial behavior. This guide covers dose design, migration and tube assays, translational interpretation, and practical troubleshooting.
-
Verapamil HCl: A Txnip-to-Phenotype Workflow
2026-09-14
Verapamil HCl is more than an L-type calcium channel blocker: it is a useful perturbation tool for connecting calcium signaling with Txnip, bone turnover, apoptosis, and inflammation. This article translates recent osteoporosis findings into practical assay and interpretation strategies.
-
In Vitro Drug Response: Beyond Relative Viability
2026-09-14
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell death are related but non-equivalent components of an anticancer response. The framework supports more precise interpretation of in vitro drug experiments by separating cytostatic effects, killing, and their different temporal patterns.
-
A-1210477: A Causal MCL-1 Apoptosis Probe
2026-09-13
Explore how the MCL-1 inhibitor A-1210477 can function as a causal probe of mitochondrial apoptosis rather than merely a cytotoxic reagent. This article connects MCL-1 biology, BAX/BAK-dependent tumor control, assay design, compound handling, and interpretation limits for rigorous cancer research.
-
Tivozanib: Interpreting VEGFR Drug Responses
2026-09-12
Tivozanib (AV-951) is a highly selective VEGFR inhibitor, but potency alone cannot explain its cellular effects. This guide shows how to pair pathway, viability, and cell-death measurements for more rigorous anti-angiogenic therapy research.
-
Ultrafiltration for Circular RNA Purification
2026-09-12
Guillen-Cuevas and colleagues evaluated ultrafiltration as a scalable way to separate protein-encoding circular RNA from linear precursor and nicked RNA contaminants. By analyzing membrane sieving and critical flux, the study achieved higher reported purity and comparable yield than size-exclusion HPLC, supporting ultrafiltration as a promising research-scale purification strategy.
-
Carbapenemase Transmission in Enterobacter cloacae
2026-09-11
Chen et al. profiled 54 carbapenem-resistant Enterobacter cloacae isolates from eight Guangdong teaching hospitals, combining gene localization, susceptibility testing, conjugation, mobile-element analysis, and ERIC-PCR typing. The study found plasmid-associated blaNDM-1, high transferability, multidrug resistance, and evidence for both clonal and horizontal dissemination, providing a practical framework for hospital resistance surveillance.
-
Tauroursodeoxycholic Acid: ER Stress Workflow
2026-09-11
Tauroursodeoxycholic Acid, or TUDCA, gives researchers a practical small-molecule way to reduce ER stress, stabilize mitochondria, and interrogate apoptosis. This workflow translates findings from subarachnoid hemorrhage research into controlled assay design for neuroinflammation, metabolic disorder studies, and other stress-sensitive models.
-
GW 4869 Hydrochloride Hydrate and Exosome Causality
2026-09-10
A translational framework for using GW 4869 hydrochloride hydrate to test whether neutral sphingomyelinase-dependent extracellular vesicle release is causally linked to lithium-enhanced osteogenesis, with guidance on controls, interpretation, and experimental readiness.